Skip to main content
. 2016 Mar 15;127(20):2451–2459. doi: 10.1182/blood-2015-12-688705

Figure 2.

Figure 2

Kaplan-Meier curves for CIR in patients stratified according to their mutational profile. Patients are separated in 3 groups: (1) TK pathway mutation associated with at least 1 mutation involving chromatin modifier or cohesin genes, (2) TK pathway mutation without mutations involving chromatin modifier or cohesin genes, and (3) other mutational profiles.